Quadrature Capital LTD Pro Qr Therapeutics N.V. Transaction History
Quadrature Capital LTD
- $4.51 Trillion
- Q1 2025
A detailed history of Quadrature Capital LTD transactions in Pro Qr Therapeutics N.V. stock. As of the latest transaction made, Quadrature Capital LTD holds 26,403 shares of PRQR stock, worth $43,036. This represents 0.0% of its overall portfolio holdings.
Number of Shares
26,403Holding current value
$43,036% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding PRQR
# of Institutions
68Shares Held
42.1MCall Options Held
30.1KPut Options Held
5.3K-
Adage Capital Partners Gp, L.L.C. Boston, MA8.1MShares$13.2 Million0.02% of portfolio
-
Privium Fund Management B.V.4.99MShares$8.13 Million1.74% of portfolio
-
Affinity Asset Advisors, LLC New York, NY3.28MShares$5.35 Million0.49% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny2.07MShares$3.38 Million0.0% of portfolio
-
Sio Capital Management, LLC New York, NY2.05MShares$3.35 Million1.03% of portfolio
About ProQR Therapeutics N.V.
- Ticker PRQR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 71,362,096
- Market Cap $116M
- Description
- ProQR Therapeutics N.V., a biopharmaceutical company, engages in the discovery and development of RNA-based therapeutics for the treatment of genetic disorders. It primarily develops sepofarsen that is in phase II/III clinical trial illuminate trial for treating leber congenital amaurosis 10 disease; and ultevursen, which is in phase II/III clin...